Loading…
BD (Becton, Dickinson and Company) formed a public-private partnership with BARDA to develop new manufacturing lines for syringes and needles in Nebraska. BARDA will invest $42 million into the $70 million capital project, and BD finalized an initial order for 50 million injection devices for COVID-19 vaccination.
“BARDA will invest an estimated $42 million into a $70 million capital project to further expand BD's operations and manufacturing capacity in Nebraska.”news.bd.com
Summarized from public sources; check the original articles before acting on it.